Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype - PubMed (original) (raw)
. 2001 Jun 26;56(12):1702-6.
doi: 10.1212/wnl.56.12.1702.
M Baker, H R Morris, N MacDonald, S Pickering-Brown, J Adamson, A J Lees, M N Rossor, N P Quinn, A Kertesz, M N Khan, J Hardy, P L Lantos, P St George-Hyslop, D G Munoz, D Mann, A E Lang, C Bergeron, E H Bigio, I Litvan, K P Bhatia, D Dickson, N W Wood, M Hutton
Affiliations
- PMID: 11425937
- DOI: 10.1212/wnl.56.12.1702
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
H Houlden et al. Neurology. 2001.
Abstract
Objective: To analyze the association of polymorphisms in the tau gene with pathologically confirmed corticobasal degeneration (CBD).
Background: The authors previously described an extended tau haplotype (H1) that covers the human tau gene and is associated with the development of progressive supranuclear palsy (PSP). The authors now extend this analysis to CBD, a neurodegenerative condition with clinical and neuropathologic similarities to PSP. Like PSP, CBD is associated with accumulation of aggregates containing the 4-repeat isoforms of tau. Because of difficulty in diagnosis of CBD, the authors only analyzed cases with pathologically confirmed CBD.
Methods: The authors collected 57 unrelated, neuropathologically confirmed cases of CBD. Tau sequencing in these cases failed to show the presence of pathogenic mutations. Polymorphisms that spanned the tau gene were analyzed in all CBD cases and controls.
Results: Analyzing tau polymorphisms in CBD cases showed that the frequency of H1 and H1/H1 was significantly increased when analyzing all cases and when separating by country of origin. H1 frequency in all CBD cases was 0.921, compared with a control frequency of 0.766 (X(2) = 9.1, p = 0.00255 [1df], OR 3.56 [8.43 > CI 95% > 1.53]). The H1/H1 frequency was also significantly higher at 0.842 compared with 0.596 in age-matched controls (X(2) = 17.42, p = 0.00016, 2df), OR 3.61 [7.05 > CI 95% > 1.85]).
Conclusions: The CBD tau association described here suggests that PSP and CBD share a similar cause, although the pathogenic mechanism behind the two diseases leads to a different clinical and pathologic phenotype.
Similar articles
- Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T, Tolosa E, Ferrer I. Scaravilli T, et al. Mov Disord. 2005 Aug;20 Suppl 12:S21-8. doi: 10.1002/mds.20536. Mov Disord. 2005. PMID: 16092076 - Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, Marlowe L, Duckworth J, Leung D, Williams D, Kilford L, Thomas N, Morris CM, Dickson D, Wood NW, Hardy J, Lees AJ, de Silva R. Pittman AM, et al. J Med Genet. 2005 Nov;42(11):837-46. doi: 10.1136/jmg.2005.031377. Epub 2005 Mar 25. J Med Genet. 2005. PMID: 15792962 Free PMC article. - Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.
Valentino RR, Tamvaka N, Heckman MG, Johnson PW, Soto-Beasley AI, Walton RL, Koga S, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA. Valentino RR, et al. Acta Neuropathol Commun. 2020 Sep 17;8(1):162. doi: 10.1186/s40478-020-01035-z. Acta Neuropathol Commun. 2020. PMID: 32943110 Free PMC article. - Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A, Munoz D. Kertesz A, et al. Dement Geriatr Cogn Disord. 2004;17(4):282-6. doi: 10.1159/000077155. Dement Geriatr Cogn Disord. 2004. PMID: 15178937 Review. - Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
Dickson DW. Dickson DW. J Neurol. 1999 Sep;246 Suppl 2:II6-15. doi: 10.1007/BF03161076. J Neurol. 1999. PMID: 10525997 Review.
Cited by
- Frontotemporal lobar degeneration: current concepts in the light of recent advances.
Kumar-Singh S, Van Broeckhoven C. Kumar-Singh S, et al. Brain Pathol. 2007 Jan;17(1):104-14. doi: 10.1111/j.1750-3639.2007.00055.x. Brain Pathol. 2007. PMID: 17493044 Free PMC article. Review. - A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity.
Poorkaj P, Raskind WH, Leverenz JB, Matsushita M, Zabetian CP, Samii A, Kim S, Gazi N, Nutt JG, Wolff J, Yearout D, Greenup JL, Steinbart EJ, Bird TD. Poorkaj P, et al. Mov Disord. 2010 Jul 30;25(10):1409-17. doi: 10.1002/mds.23085. Mov Disord. 2010. PMID: 20629132 Free PMC article. - Corticobasal syndrome with visual hallucinations and probable REM-sleep behavior disorder: an autopsied case report of a patient with CBD and LBD pathology.
Naasan G, Shany-Ur T, Sidhu M, Barton C, Ketelle R, Shdo SM, Kramer JH, Miller BL, Seeley WW. Naasan G, et al. Neurocase. 2019 Feb-Apr;25(1-2):26-33. doi: 10.1080/13554794.2019.1604973. Epub 2019 Apr 22. Neurocase. 2019. PMID: 31006355 Free PMC article. - Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease.
Fernández-Nogales M, Lucas JJ. Fernández-Nogales M, et al. Front Cell Neurosci. 2020 Jan 17;13:574. doi: 10.3389/fncel.2019.00574. eCollection 2019. Front Cell Neurosci. 2020. PMID: 32009905 Free PMC article. Review. - The corticobasal syndrome-Alzheimer's disease conundrum.
Hassan A, Whitwell JL, Josephs KA. Hassan A, et al. Expert Rev Neurother. 2011 Nov;11(11):1569-78. doi: 10.1586/ern.11.153. Expert Rev Neurother. 2011. PMID: 22014136 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous